Results 261 to 270 of about 136,614 (358)

Serum N-glycan NA3Fb identified as a prognostic biomarker of poor outcome in HBV-related hepatocellular carcinoma. [PDF]

Cancer Cell Int
Kang P, Wang M, Liu J, Wang J, Li X, Jiang B, Lin R, Zhong S, Xu L, Chen C, Li B, Shen T.   +11 more
europepmc   +1 more source

The preS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines

Inna Tulaeva, Felix Lehmann, Nora Goldmann, Alexandra Dubovets, Daria Trifonova, Mikhail Tulaev, Carolin Cornelius, Milena Weber, Margarete Focke‐Tejkl, А. В. Караулов, Rainer Henning, Ursula Wiedermann, Dieter Glebe, Rudolf Valenta   +13 more
openalex   +2 more sources

Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B. [PDF]

World J Gastroenterol
Fu YC, Li J, Wang JY, Zhang YW, Yan F, Chen J, Du Q, Yang C, Liang J, Ye Q, Xiang HL.   +10 more
europepmc   +1 more source

Development and Validation of a Predictive Model for HBsAg Seroclearance After Peg-IFN-Based Therapy: A Multicentre Study. [PDF]

Drug Des Devel Ther
Liu HH, Jiang XM, Cui C, Zhao J, Xu J, Wang SK, Hu LH, Yin YP, Wang X, Yu LJ, Xu C, Zhao ZH, Xing YQ, Liu Y, Wang K, Gao S.   +15 more
europepmc   +1 more source

Characterisation of People Living With Chronic Hepatitis B Virus Infection in England and Stratification by HBsAg Levels: A Cross-Sectional Study. [PDF]

J Viral Hepat
Drysdale M, Gillespie IA, Christensen D, Davies J, Woods K, Roadknight G, Little S, Salih H, Várnai KA, Noble T, Cooke GS, Glampson B, Papadimitriou D, Mayer E, Khakoo SI, Davis C, Borca F, English L, Nastouli E, Matthews PC, Barnes E, Wang T.   +21 more
europepmc   +1 more source

Predictors of low-level viremia in chronic hepatitis B and the efficacy of pegylated interferon-alpha: a real-world study. [PDF]

Virol J
Zhang W, Chen J, Sun W, Xie N, Tian F, Zhang W, Ruan Q, Song J.   +7 more
europepmc   +1 more source

Liver transplantation under cyclosporine: a decade of experience. [PDF]

, 1991
Fung, JJ, Gordon, RD, Iwatsuki, S, Starzl, TE, Staschak, SM, Stieber, A, Todo, S, Tzakis, AG   +7 more
core  

HBVZ10, an AAV8 vector-based new HBV therapy candidate for cccDNA elimination. [PDF]

Mol Ther Methods Clin Dev
Zhang BH, Zhou Y, Horrigan S, Luckenbaugh L, Hu J, Zoulim F, Zhang YY.   +6 more
europepmc   +1 more source